Medicis Pharma (MRX) Reports In-Line Q4 EPS of 60c; Guides Q1
Medicis Pharmaceutical Corp. (NYSE: MRX) reported Q4 EPS of $0.60 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
